Monitoring and Treatment of Patients Undergoing Immunotherapy With Anti-CD20 Who are Exposed to HBV

被引：6
|
作者：
Seto, Wai-Kay [1 ,2 ,3 ]
Chan, Thomas Sau-Yan [1 ]
Hwang, Yu-Yan [1 ]
Mak, Lung-Yi [1 ]
Wong, Danny Ka-Ho [1 ,2 ]
Fung, James [1 ,2 ]
Liu, Kevin Sze-Hang [1 ]
Cheung, Ka-Shing [1 ]
Lai, Ching-Lung [1 ,2 ]
Kwong, Yok-Lam [1 ]
Yuen, Man-Fung [1 ,2 ]
机构：
[1] Univ Hong Kong, Dept Med, Queen Mary Hosp, 102 Pokfulam Rd, Hong Kong, Peoples R China
[2] Univ Hong Kong, State Key Lab Liver Res, Queen Mary Hosp, Hong Kong, Peoples R China
[3] Univ Hong Kong, Shenzhen Hosp, Dept Med, Shenzhen, Peoples R China
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 17卷 / 07期
关键词：
HEPATITIS-B REACTIVATION; LYMPHOMA; CHEMOTHERAPY;
D O I：
10.1016/j.cgh.2018.09.020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1410 / 1412
页数：3
相关论文
共 50 条
  • [1] Immunotherapy with anti-CD20 compounds
    von Schilling, C
    [J]. SEMINARS IN CANCER BIOLOGY, 2003, 13 (03) : 211 - 222
  • [2] Resolved HBV and anti-CD20 therapy
    Hicks, Lisa K.
    Feld, Jordan J.
    [J]. BLOOD, 2019, 133 (02) : 104 - 106
  • [3] Feasibility of strategic monitoring in patients with prior HBV exposure undergoing anti-CD20 monoclonal antibody therapy: a prospective observational study
    Seto, Wai-Kay
    Mak, Lung-Yi
    Liu, Sze Hang Kevin
    Cheung, Ka-Shing
    Fung, James
    Wong, Danny
    Lai, Ching-Lung
    Yuen, Man-Fung
    [J]. HEPATOLOGY, 2017, 66 : 1009A - 1009A
  • [4] HBV Care Map for Patients Receiving Anti-CD20 Therapy
    Liederman, Zachary
    Berinstein, Neil
    Crump, Michael
    Hwang, Jessica
    Janssen, Harry L. A.
    Kouroukis, C. Tom
    Leung, Patricia
    Lok, Anna
    Yim, Colina
    Zelenetz, Andrew D.
    Chan, Kelvin
    Feld, Jordan
    Hicks, Lisa K.
    [J]. BLOOD, 2017, 130
  • [5] Can NK cells play a role in anti-CD20 immunotherapy for CLL patients?
    Le Garff-Tavemier, Magali
    De Romeuf, Christophe
    Teillaud, Jean-Luc
    Decocq, Julie
    Dutertre, Charles-Antoine
    Debre, Patrice
    Merle-Beral, Helene
    Vieillard, Vincent
    [J]. BLOOD, 2007, 110 (11) : 913A - 913A
  • [6] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    [J]. RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [7] Concepts in radiotherapy and immunotherapy: Anti-CD20 mechanisms of action and targets
    Maloney, DG
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (01) : S19 - S26
  • [8] Anti-CD20 (rituximab) treatment for atopic eczema
    Sediva, Anna
    Kayserova, Jana
    Vernerova, Eva
    Polouckova, Andrea
    Capkova, Stepanka
    Spisek, Radek
    Bartunkova, Jirina
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (06) : 1515 - 1516
  • [9] Treatment of multiple sclerosis with Anti-CD20 antibodies
    Barun, Barbara
    Bar-Or, Amit
    [J]. CLINICAL IMMUNOLOGY, 2012, 142 (01) : 31 - 37
  • [10] Anti-CD20 in lupus
    Isenberg, DA
    Leandro, MJ
    Ehrenstein, MR
    Edwards, JCW
    Manson, J
    Cambridge, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 27 - 28
12345